1. Jing J, Nelson C, Paik J, Shirasaka Y, Amory JK, Isoherranen N. Physiologically Based Pharmacokinetic Model of All-trans-Retinoic Acid with Application to Cancer Populations and Drug Interactions. J Pharmacol Exp Ther. 2017 May;361(2):246-258. doi: 10.1124/jpet.117.240523. Epub 2017 Mar 8. 2. Sun B, Liu K, Han J, Zhao LY, Su X, Lin B, Zhao DM, Cheng MS. Design, synthesis, and biological evaluation of amide imidazole derivatives as novel metabolic enzyme CYP26A1 inhibitors. Bioorg Med Chem. 2015 Oct 15;23(20):6763-73. doi: 10.1016/j.bmc.2015.08.019. Epub 2015 Aug 20. 23(6):1356-65. doi: 10.1016/j.bmc.2014.11.036. Epub 2015 Jan 21. 102(1):272-281.e2. doi: 10.1016/j.fertnstert.2014.03.042. Epub 2014 May 10. 5. Regen F, Heuser I, Herzog I, Hellmann-Regen J. Striking growth-inhibitory effects of minocycline on human prostate cancer cell lines. Urology. 2014 Feb;83(2):509.e1-6. doi: 10.1016/j.urology.2013.10.029. Epub 2013 Dec 19. 256(1-2):1-6. doi: 10.1016/j.jneuroim.2012.11.005. Epub 2013 Feb 4. 36(3):517-23. doi: 10.1002/jssc.201200824. Epub 2013 Jan 10. 98(6):1557-62. doi: 10.1016/j.fertnstert.2012.07.1132. Epub 2012 Aug 25. 54(19):6803-11. doi: 10.1021/jm200695m. Epub 2011 Sep 8. 143(6):1170-6. doi: 10.1046/j.1365-2133.2000.03884.x.